Johnny Urrutia
Medical · Twin Falls, IDNPI 1831290097
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,864 of the $2,435 with a category attached, or 76.6%. 18 manufacturers reported payments, led by Medtronic at 36.3% of the total. Reporting peaked in 2024 at $745 and has fallen 54.2% since, to $342 in 2025.
Across 136 payments — averaging $17.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$884
- Boston Scientific$492
- Curonix LLC$431
- Phenox Inc.$109
- Collegium Pharmaceutical, Inc.$109
- AbbVie$81
- plus $330 from 12 others
What the payments were for
- Travel & lodging$51621%
- Food & beverage$1,86477%
- Education$542%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 63 | $884 |
| Boston Scientific | 44 | $492 |
| Curonix LLC | 5 | $431 |
| Phenox Inc. | 1 | $109 |
| Collegium Pharmaceutical, Inc. | 2 | $109 |
| AbbVie | 4 | $81 |
| Biodelivery Sciences International, Inc. | 3 | $50 |
| GRT US Holding, Inc. | 1 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $43 |
| Idorsia Pharmaceuticals US Inc | 2 | $37 |
| Vertex | 2 | $33 |
| Saluda Medical Americas, Inc. | 1 | $28 |
| Impel Pharmaceuticals Inc. | 1 | $23 |
| Averitas Pharma Inc. | 1 | $18 |
| Scilex Pharmaceuticals Inc. | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
| Pfizer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,435 in reported general payments places this provider in the 85th percentile of 265 medical providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 80 | $58,096 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 785 | $22,415 |
| MovantikNaloxegol Oxalate | 56 | $21,266 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 478 | $13,373 |
| Buprenorphine | 25 | $13,098 |
| OxycontinOxycodone Hcl | 24 | $8,748 |
| Pregabalin | 187 | $7,047 |
| Oxycodone Hcl | 269 | $6,221 |
| Gabapentin | 419 | $4,939 |
| Morphine Sulfate | 112 | $3,500 |
| Diclofenac Sodium | 47 | $3,088 |
| Morphine Sulfate ErMorphine Sulfate | 168 | $2,771 |
| Celecoxib | 48 | $2,533 |
| Metaxalone | 25 | $2,519 |
| Tizanidine Hcl | 176 | $1,772 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $109 | $58,09680 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 265 medical providers in Idaho.
Other medical in Twin Falls
- Michael WucinichTwin Falls$8K
- Cameron FreemanTwin Falls$3K
- Brett ZundelTerreton$71K
- Jessica BishopBoise$60K
- Kyle GeorgeMeridian$19K
- Jed BartschiIdaho Falls$11K
- Dallin GamblesRexburg$10K
- Cali BradberryBoise$9K
- Weldon RichardsonIdaho Falls$8K
- Wade ChristensenIdaho Falls$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.